Ars Operation Drug Patent Portfolio
Ars Operation owns 1 orange book drug protected by 8 US patents Given below is the list of Ars Operation's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10682414 | Intranasal epinephrine formulations and methods for the treatment of disease | 06 Feb, 2039 | Active |
| US11191838 | Intranasal epinephrine formulations and methods for the treatment of disease | 06 Feb, 2039 | Active |
| US11717571 | Intranasal epinephrine formulations and methods for the treatment of disease | 06 Feb, 2039 | Active |
| US11744895 | Intranasal epinephrine formulations and methods for the treatment of disease | 06 Feb, 2039 | Active |
| US11918655 | Intranasal epinephrine formulations and methods for the treatment of disease | 06 Feb, 2039 | Active |
| US12324838 | Intranasal epinephrine formulations and methods for the treatment of disease | 06 Feb, 2039 | Active |
| US10576156 | Compositions for drug administration | 06 Feb, 2038 | Active |
| US11173209 | Compositions for drug administration | 06 Feb, 2038 | Active |
Latest Legal Activities on Ars Operation's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ars Operation.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent Grant Mailed | 17 Jun, 2025 | US12324838 |
| Mail Patent eGrant Notification | 10 Jun, 2025 | US12324838 |
| Email Notification | 10 Jun, 2025 | US12324838 |
| Recordation of Patent eGrant | 10 Jun, 2025 | US12324838 |
| Patent eGrant Notification | 10 Jun, 2025 | US12324838 |
| Patent Issue Date Used in PTA Calculation | 10 Jun, 2025 | US12324838 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 09 Jun, 2025 | US11191838 |
| Email Notification | 31 May, 2025 | US12324838 |
| Issue Notification Mailed | 28 May, 2025 | US12324838 |
| Application Is Considered Ready for Issue | 09 May, 2025 | US12324838 |
| Dispatch to FDC | 09 May, 2025 | US12324838 |
| Issue Fee Payment Received | 07 May, 2025 | US12324838 |
| Issue Fee Payment Verified | 07 May, 2025 | US12324838 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 24 Apr, 2025 | US11173209 |
| Review Certificate Mailed | 08 Apr, 2025 | US10682414 |
Ars Operation's Drug Patent Litigations
Ars Operation's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Aug 12, 2021, against patent number US10682414. The petitioner Amphastar Pharmaceuticals, Inc., challenged the validity of this patent, with Aegis Therapeutics, LLC et al. as the respondent. Click below to track the latest information on how companies are challenging Ars Operation's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US10682414 | August, 2021 |
Final Written Decision
(09 Feb, 2023)
| Aegis Therapeutics, LLC et al. | Amphastar Pharmaceuticals, Inc. |
Ars Operation's Family Patents
Recent FDA approvals and tentative approvals for Ars Operation
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Innovator drugs
Includes innovator drug submissions that appear in FDA approval and tentative approval disclosures.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Neffy |
SUPPL-2
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Efficacy | 25 Feb, 2026 |
Ars Operation Drug List
Given below is the complete list of Ars Operation's drugs and the patents protecting them.
1. Neffy
Neffy is protected by 8 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10682414 | Intranasal epinephrine formulations and methods for the treatment of disease |
06 Feb, 2039
(12 years from now)
| Active |
| US11191838 | Intranasal epinephrine formulations and methods for the treatment of disease |
06 Feb, 2039
(12 years from now)
| Active |
| US11717571 | Intranasal epinephrine formulations and methods for the treatment of disease |
06 Feb, 2039
(12 years from now)
| Active |
| US11744895 | Intranasal epinephrine formulations and methods for the treatment of disease |
06 Feb, 2039
(12 years from now)
| Active |
| US11918655 | Intranasal epinephrine formulations and methods for the treatment of disease |
06 Feb, 2039
(12 years from now)
| Active |
| US12324838 | Intranasal epinephrine formulations and methods for the treatment of disease |
06 Feb, 2039
(12 years from now)
| Active |
| US10576156 | Compositions for drug administration |
06 Feb, 2038
(11 years from now)
| Active |
| US11173209 | Compositions for drug administration |
06 Feb, 2038
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Neffy's drug page